RLN3
Relaxin-3
Also known as: H3, REL3_HUMAN, RXN3, ZINS4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WXF3
- Gene
- RLN3
- Ensembl
- ENSG00000171136
- Chromosome
- 19
- Canonical length
- 142 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the relaxin family of insulin-like hormones that is expressed predominantly in the brain and plays a role in physiological processes such as stress, memory and appetite regulation. The encoded protein is a precursor that is proteolytically processed to generate a heterodimeric mature form consisting A and B chains interlinked by disulfide bonds. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2015]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>Q8WXF3|RLN3
1 MARYMLLLLL AVWVLTGELW PGAEARAAPY GVRLCGREFI RAVIFTCGGS RWRRSDILAH
61 EAMGDTFPDA DADEDSLAGE LDEAMGSSEW LALTKSPQAF YRGRPSWQGT PGVLRGSRDV
121 LAGLSSSCCK WGCSKSEISS LCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RLN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 2.6 nTPM
Expression across tissuesHPA
Tissue
- testis: 2.6 nTPM
- parathyroid gland: 1.5 nTPM
- prostate: 0.6 nTPM
- spleen: 0.6 nTPM
- lung: 0.3 nTPM
- midbrain: 0.3 nTPM
Single-cell type
- brain inhibitory neurons: 0.7 nCPM
- other brain neurons: 0.2 nCPM
- ependymal cells: 0.1 nCPM
- microglia: 0.1 nCPM
- oligodendrocyte progenitor cells: 0.1 nCPM
- adipocytes: 0 nCPM
Immune cell
- naive B-cell: 0.5 nTPM
- T-reg: 0.3 nTPM
- myeloid DC: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- pons: 0.4 nTPM
- midbrain: 0.3 nTPM
- thalamus: 0.2 nTPM
- cerebellum: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- hypothalamus: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.16
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RLN3 as an antibody target. Whether an autoantibody or antibody against RLN3 could matter depends on whether native RLN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RLN3 is annotated as secreted, so native RLN3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label RLN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...